Boehringer Ingelheim Pharmaceuticals, Inc. recalls Catapres (clonidine hydrochloride, USP) 0.1 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharm
Recalled November 4, 2020 · FDA recall D-0051-2021 · Boehringer Ingelheim Pharmaceuticals
Hazard
An extraneous peak was observed for dissolution testing. · FDA Class II
Units
13,270 bottles/100 tablets each
Sold at
Distributed Nationwide in the USA and Puerto Rico
Description
An extraneous peak was observed for dissolution testing.
Product
Catapres (clonidine hydrochloride, USP) 0.1 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877, Made in Germany, NDC, 0597-0006-01
Manufacturer(s)
Boehringer Ingelheim Pharmaceuticals, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →